Still not much info and trouble brewing for Theranos
The WIRED story below reports on an article from the Wall Street Journal about Theranos having trouble living up to their claims. I was skeptical about the company when news hype circled about Theranos over a year ago.
Minimal volume with minimal information
https://plus.google.com/u/0/+ChadHaney/posts/Zd4UKZizmkP
There wasn’t much detail about the science behind their idea and that’s a red flag. The Wired article below even mentions peer reviewed journal articles. You’ve probably heard me and other moderator’s of the Science on Google+ community always tell ‘skeptics’ (often conspiracy theorists that call themselves skeptics), that only peer reviewed publications can be trusted when one has extraordinary claims.
I’ve written about skepticism already:
Skepticism doesn’t equal question all teh things
https://plus.google.com/u/0/+ChadHaney/posts/iXZqcz7bDqB
an hype with preclinical results:
Overselling preclinical results
https://plus.google.com/u/0/+ChadHaney/posts/UWn7Q9hTuHm
Finally, if you missed my piece on how drugs get to market, you might want to read:
Bench to Bedside
http://goo.gl/63mKa
http://www.wired.com/2015/10/theranos-scandal-exposes-the-problem-with-techs-hype-cycle/?mbid=social_gplus